| Quest – Discovery Stage Research Projects | University of California, Los Angeles | Defining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency |
$1,353,084 |
| Quest – Discovery Stage Research Projects | University of California, Los Angeles | Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome |
$1,512,333 |
| Therapeutic Translational Research Projects | University of California, Los Angeles | Hematopoietic Stem Cell Gene Editing for X-linked Agammaglobulinemia (XLA) |
$4,304,883 |
| Therapeutic Translational Research Projects | University of California, Los Angeles | Ex Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome |
$4,896,628 |
| Progression Award – Discovery Stage Research Projects | University of California, Los Angeles | Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 |
$234,000 |
